Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with the scientific community on the regulatory changes needed to ensure that the UK will have continued alignment with EU regulations on clinical trials after the UK leaves the EU.

The Government has made clear that a key priority through the negotiations will be to ensure that the United Kingdom remains one of the best places in the world for science and innovation, including on clinical trials. We are in regular contact with the scientific community through the Ministerial and industry co-chaired UK-European Union Life Sciences Steering Group. Outside of this group we have consistent contact with industry and research charities on clinical trials.